Morningside Venture Investment's Net Worth
Morningside Venture Investment's net worth is estimated to be at least $60,174,353.26 as of 11/08/2024. CoreStreet's estimation of Morningside Venture Investment's net worth is based on their sale of stock and current holding of stock.
Morningside Venture Investment is Major Shareholder at Amylyx Pharmaceuticals Inc. They have executed at least 23 trades of stock as per SEC Form 4 filings. Their most recent trade was for 29,048 units of AMLX stock on 03/29/2023. Their biggest sale was on 03/14/2023 when they sold 70,714 units of Amylyx Pharmaceuticals Inc stock for $2,442,461.56. They typically trade 3 times per year.
Total value of insider buys:
- $47,281,762.12
Total value of insider sells:
- $12,892,591.14
Most recent insider trade:
- March 29, 2023
Morningside Venture Investment's Insider Trading History
| Amylyx Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 29, 2023 | Major Shareholder | 29,048 | $30.45 | Sell | $884,511.60 |
March 27, 2023 | Major Shareholder | 60,964 | $30.50 | Sell | $1,859,402.00 |
March 21, 2023 | Major Shareholder | 63,448 | $31.91 | Sell | $2,024,625.68 |
March 16, 2023 | Major Shareholder | 9,122 | $32.55 | Sell | $296,921.10 |
March 14, 2023 | Major Shareholder | 70,714 | $34.54 | Sell | $2,442,461.56 |
March 2, 2023 | Major Shareholder | 50,000 | $33.75 | Sell | $1,687,500.00 |
Feb. 22, 2023 | Major Shareholder | 50,000 | $34.73 | Sell | $1,736,500.00 |
| Kezar Life Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 6, 2023 | Major Shareholder | 40,000 | $6.88 | Sell | $275,200.00 |
Feb. 3, 2023 | Major Shareholder | 25,000 | $7.15 | Sell | $178,750.00 |
Jan. 30, 2023 | Major Shareholder | 30,000 | $6.91 | Sell | $207,300.00 |
Jan. 25, 2023 | Major Shareholder | 50,000 | $6.85 | Sell | $342,500.00 |
Jan. 23, 2023 | Major Shareholder | 80,000 | $6.81 | Sell | $544,800.00 |
Jan. 17, 2023 | Major Shareholder | 6,114 | $6.79 | Sell | $41,514.06 |
Jan. 12, 2023 | Major Shareholder | 5,000 | $6.77 | Sell | $33,850.00 |
Jan. 5, 2023 | Major Shareholder | 12,162 | $6.97 | Sell | $84,769.14 |
Oct. 3, 2022 | Major Shareholder | 28,700 | $8.78 | Sell | $251,986.00 |
Feb. 4, 2020 | Major Shareholder | 3,800,000 | $2.60 | Buy | $9,880,000.00 |
June 25, 2018 | Major Shareholder | 250,000 | $15.00 | Buy | $3,750,000.00 |
| GreenLight Biosciences Holdings | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 11, 2022 | Major Shareholder | 3,061,224 | $3.92 | Buy | $11,999,998.08 |
| Apellis Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 18, 2021 | Major Shareholder | 250,000 | $40.00 | Buy | $10,000,000.00 |
March 11, 2019 | Major Shareholder | 441,176 | $17.00 | Buy | $7,499,992.00 |
Sept. 21, 2018 | Major Shareholder | 81,323 | $19.48 | Buy | $1,584,172.04 |
Sept. 19, 2018 | Major Shareholder | 140,000 | $18.34 | Buy | $2,567,600.00 |